The global medical robots market size was valued at USD 20.21 billion in 2025 and is projected to grow from USD 23.21 billion in 2026 to USD 71.13 billion by 2034, registering a CAGR of 15.03% during the forecast period (2026–2034). North America dominated the medical robots market with a market share of 39.12% in 2025.
Medical robots are advanced robotic systems designed to assist healthcare professionals in performing surgical procedures, rehabilitation, diagnostics, hospital logistics, and patient care with greater precision. These systems enhance procedural accuracy, improve minimally invasive interventions, and reduce human error.
The medical robots market demand is driven by the rising adoption of minimally invasive surgeries, the growing shortage of skilled healthcare professionals, and continuous technological advancements in robotics and artificial intelligence. Increasing investments in healthcare automation, expanding hospital infrastructure, and growing acceptance of robot-assisted procedures are also contributing to medical robots market growth.
Download a Free Sample To learn more about this report,
The medical robots market is highly exposed to supply chain disruptions because it relies on specialized electronic components, semiconductors, robotic actuators, precision sensors, and medical-grade materials sourced through complex global supplier networks. Interruptions in raw material availability, component manufacturing, international transportation, and logistics operations can delay production, increase manufacturing costs, and extend equipment delivery timelines for hospitals and healthcare providers worldwide. Despite these challenges, the market is experiencing a capacity-constrained recovery, driven by supplier diversification, localized manufacturing, strategic inventory management, digital supply chain optimization, and stronger procurement resilience.
Healthcare providers are increasingly integrating artificial intelligence into medical robotic systems to improve surgical planning, intraoperative guidance, and clinical decision-making. This transition from robot-assisted execution to AI-assisted procedural intelligence is enhancing surgical precision, workflow efficiency, and patient outcomes across multiple specialties. AI-enabled robots can analyze imaging data, track surgical instruments, and provide real-time recommendations during procedures.
Healthcare facilities are increasingly deploying autonomous medical robots beyond operating rooms for logistics, pharmacy automation, patient monitoring, and hospital support services. This transition from procedure-specific robotics to hospital-wide automation is improving operational efficiency, reducing staff workload, and optimizing resource utilization. For example, Swisslog Healthcare's autonomous mobile robots are widely used in hospitals to automate the transportation of medications, laboratory samples, and medical supplies.
The medical robots market forecasts continued investment activity driven by the rising adoption of robot-assisted surgeries, increasing demand for AI-enabled healthcare automation, and continuous innovation in minimally invasive surgical technologies. Investors are focusing on companies developing next-generation robotic surgery platforms, autonomous healthcare robots, and intelligent digital surgical ecosystems that improve clinical outcomes, workflow efficiency, and hospital productivity.
Key Investment and Funding Activities in Medical Robots Market, 2025–2026
SS Innovations
USD 18.6 million (Private Placement)
In March 2026, SS Innovations raised capital to expand global commercialization of its SSi Mantra robotic surgery system and support regulatory and market expansion in the US and Europe.
ForSight Robotics
USD 125 million (Series B)
In June 2025, ForSight Robotics raised Series B funding to accelerate development of the ORYOM ophthalmic robotic surgery platform, initiate first-in-human clinical trials, and expand commercialization activities.
Increasing Adoption of Minimally Invasive Surgeries and Growing Healthcare Workforce Shortages Drives Market
The rising volume of robot-assisted minimally invasive procedures is driving demand for medical robots as healthcare providers increasingly adopt advanced robotic platforms to improve surgical precision and patient outcomes. The continued growth in robotic procedure volumes is encouraging hospitals to expand robotic surgery programs across urology, general surgery, gynecology, thoracic, and colorectal specialties while investing in additional robotic platforms. This increasing procedural adoption is strengthening demand for medical robots and accelerating market growth globally.
The increasing shortage of skilled healthcare professionals is accelerating demand for medical robots that automate repetitive clinical and hospital tasks while improving operational efficiency. Healthcare providers are deploying robotic systems for surgery, rehabilitation, pharmacy automation, and hospital logistics to optimize workforce utilization and maintain quality of care. This expanding adoption is encouraging continuous investments in advanced robotic technologies, strengthening both supply and demand across the industry.
High Capital Investment and Limited Clinical and Economic Justification Restrain Market Expansion
Medical robotic systems require significant upfront investment for equipment, installation, operating room integration, and surgeon training, while ongoing maintenance and service contracts add to the total cost of ownership. These high costs make adoption challenging, particularly for small and mid-sized hospitals with limited capital budgets. As a result, purchasing decisions are often delayed, restricting the broader adoption and growth of the medical robots market.
Medical robotic systems demonstrate the greatest value in complex and specialized procedures, but for many routine surgeries, conventional laparoscopic or open techniques continue to deliver comparable clinical outcomes at significantly lower costs. This limits the economic justification for hospitals to deploy robotic platforms across all surgical disciplines.
Expansion of Ambulatory Surgery Centers and Integration of AI & Digital Surgical Ecosystems Offer Growth Opportunities to Market Players
The increasing shift of minimally invasive procedures to ambulatory surgery centers is creating significant growth opportunities for medical robot manufacturers by expanding demand for compact and cost-efficient robotic platforms. According to the Ambulatory Surgery Center Association (ASCA), more than 6,300 Medicare-certified ASCs were operating in the US in 2025, with procedure volumes continuing to increase as payers encourage outpatient care. This expansion is creating new commercial opportunities for robotic systems designed specifically for smaller surgical facilities.
The growing adoption of AI-powered surgical planning, real-time analytics, and digital operating room platforms is creating new opportunities for medical robot developers and healthcare technology providers. Future robotic systems are expected to combine imaging, navigation, predictive analytics, and workflow optimization to improve surgical efficiency and clinical decision-making. This opportunity is driving investments in intelligent robotic platforms by companies such as Intuitive Surgical, Medtronic, and Johnson & Johnson MedTech, which are expanding their AI-enabled digital surgery ecosystems to strengthen their competitive position.
Rapid Technology Obsolescence and Managing Cybersecurity Risks Challenges Market Growth
Continuous advancements in robotic hardware, artificial intelligence, imaging technologies, and digital surgery platforms shorten product innovation cycles in the medical robots market. Hospitals often delay procurement decisions due to concerns that newly acquired robotic systems may become outdated before achieving full return on investment. This purchasing hesitation extends replacement cycles, slows new system installations, and limits the pace of market expansion, particularly among budget-constrained healthcare providers and emerging healthcare markets.
As medical robots become increasingly connected with hospital networks, cloud platforms, and AI-enabled surgical software, cybersecurity and software reliability have become critical challenges. System vulnerabilities, software glitches, or cyberattacks can disrupt surgical workflows, delay procedures, and increase regulatory scrutiny, slowing technology adoption. The US FDA issued a cybersecurity advisory related to vulnerabilities in certain medical devices connected to hospital networks, prompting manufacturers across the medical device industry to strengthen software security and post-market monitoring, increasing development costs and commercialization timelines.
The instrument & accessories segment accounted for a share of 31.49% in 2025, as robotic-assisted procedures require dedicated instruments and accessories with limited reuse cycles, generating recurring revenue throughout the system lifecycle. Increasing procedure volumes and the expansion of robotic surgery into additional specialties continue to accelerate replacement demand.
The robotic systems segment is expected to grow at a CAGR of around 15.84% during the forecast period due to hospitals upgrading to AI-enabled robotic platforms with improved visualization, automation, and multispecialty capabilities. Expanding regulatory approvals and the entry of new robotic manufacturers are increasing system installations across developed and emerging healthcare markets.
In 2025, hospitals accounted for a share of 42.78% in 2025, as they perform the highest volume of complex procedures requiring advanced robotic capabilities and multidisciplinary surgical teams. Their stronger capital budgets and access to hybrid operating rooms support continuous investment in robotic technologies.
The ambulatory surgical centers segment is expected to grow at a CAGR of 16.05% during the forecast period, driven by compact robotic systems making outpatient robotic surgery commercially viable for high-volume minimally invasive procedures. Growing payer preference for lower-cost outpatient care is encouraging ASCs to adopt robotic platforms for selected surgical specialties.
North America: Market Dominance Led by Early Adoption of Robotic Assisted Surgery and Strong Healthcare Technology Investments
The North America medical robots market accounted for the largest regional share of 39.12% in 2025, driven by early adoption of robotic-assisted surgery, strong integration of artificial intelligence into surgical workflows, and high investment in digital operating room technologies. The region benefits from the presence of leading medical robotics innovators, established robotic surgery training ecosystems, widespread clinical acceptance across multiple specialties, and continuous technological advancements that accelerate the commercialization and adoption of next-generation medical robotic systems.
The US medical robots market was valued at USD 6.89 billion in 2025, driven by increasing adoption of robot-assisted minimally invasive procedures, growing investments in AI-enabled surgical technologies, and rapid expansion of robotic surgery programs across hospitals. The country is home to major medical robot manufacturers, advanced academic medical centers, and high-volume surgical facilities that continuously adopt next-generation robotic platforms.
The medical robots market in Canada was valued at USD 1.01 billion in 2025, supported by rising investments in healthcare modernization, growing adoption of minimally invasive surgical techniques, and expansion of robotic surgery programs at leading academic hospitals. Public healthcare institutions are increasingly investing in advanced robotic technologies to improve surgical outcomes, optimize operating room efficiency, and address workforce shortages.
Asia Pacific: Fastest Growth Driven by Expanding Domestic Robotics Manufacturing and Government Backed Healthcare Digitalization
The Asia Pacific medical robots market is expected to grow at a CAGR of 16.82 during the forecast period, showcasing the fastest regional growth. Growth is supported by expanding domestic medical robotics manufacturing, increasing government support for healthcare digitalization, and rising adoption of robotic-assisted surgery across major economies. The region also focuses on increasing localization of robotic technologies, rapid expansion of high-end tertiary hospitals, and growing medical tourism.
The China medical robots market was valued at USD 1.22 billion in 2025, supported by rapid expansion of robot-assisted surgery across provincial healthcare systems and increasing integration of artificial intelligence into clinical workflows. The country's growing focus on precision medicine, rising number of specialized minimally invasive surgery centers, and expanding clinical research in surgical robotics also drive market growth.
The India medical robots market was valued at USD 622.67 million in 2025, fueled by increasing availability of robotic surgery through public-private healthcare partnerships and the rising establishment of Centers of Excellence dedicated to robotic-assisted procedures. Growing collaborations between hospitals and medical colleges for robotic surgery education, increasing demand for complex cancer and transplant surgeries, and expanding health insurance coverage for advanced surgical interventions support the adoption of medical robotic systems across the country.
The Japan medical robots market was valued at USD 718.44 million in 2025, supported by growing demand for highly precise, minimally invasive procedures and widespread adoption of robotic technologies in university hospitals. Strong emphasis on translational medical research, increasing clinical evaluation of next-generation robotic systems, and the integration of advanced imaging and navigation technologies into surgical workflows continue to accelerate market growth across the country.
The medical robots market competitive landscape is moderately consolidated, with competition led by global medical technology companies specializing in robotic surgery, rehabilitation, hospital automation, and image-guided intervention systems. Leading players compete through continuous innovation in robotic precision, artificial intelligence integration, and digital surgery platforms. The medical robots market ecosystem is shaped by technological advancements, regulatory compliance, increasing adoption of minimally invasive procedures, and growing investments in healthcare automation.
July 2026: Stryker announced the US commercial launch of Mako RPS (Robotic Power System), expanding its Mako robotics portfolio with a handheld robotic platform for total knee replacement procedures.
July 2026: Johnson & Johnson MedTech received US FDA De Novo marketing authorization for the OTTAVA Robotic Surgical System, enabling commercial entry into the US soft-tissue robotic surgery.
September 2025: Siemens Healthineers and Stryker announced a strategic partnership to jointly develop robotic solutions for neurovascular interventions.
September 2025: Microbot Medical received US FDA 510(k) clearance for its LIBERTY Endovascular Robotic System, the first FDA-cleared single-use, remotely operated robotic system for peripheral endovascular procedures.
Customize This Report to Match Your Strategic Objectives
Author's Details
Senior Research Associate
Dhanashri Bhapakar is a Senior Research Associate with 3+ years of experience in the Biotechnology sector. She focuses on tracking innovation trends, R&D breakthroughs, and market opportunities within biopharmaceuticals and life sciences. Dhanashri’s deep industry knowledge enables her to provide precise, data-backed insights that help companies innovate and compete effectively in global biotech markets.
We are featured on:
sales@straitsresearch.com